Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Answer questions and earn CME/CNE This is a review of the major changes in the American
Joint Committee on Cancer staging manual, eighth edition, for differentiated and anaplastic …

Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …

In October 2016, the American Joint Committee on Cancer (AJCC; www. cancerstaging. org)
published the eighth edition of the AJCC/TNM cancer staging system, which will replace the …

Background: Age is a critical factor in outcome for patients with well-differentiated thyroid
cancer. Currently, age 45 years is used as a cutoff in staging, although there is increasing …

Background: The American Thyroid Association (ATA), the European Association of Nuclear
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …

Purpose Patient age is considered to play a unique prognostic role in papillary thyroid
cancer (PTC), with a distinct staging dichotomization at 45 years of age. This is based on …

Iodine-resistant cancers account for the vast majority of thyroid related mortality and, until
recently, there were limited therapeutic options. However, over the last decade our …

Purpose For the past 65 years, patient age at diagnosis has been widely used as a major
mortality risk factor in the risk stratification of papillary thyroid cancer (PTC), but whether this …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …